Cadrenal Therapeutics downsizes IPO, looks to raise $7 million
There has been an increase in the number of pharma companies taking the IPO route to enhance their research and development activities — the trend is continuing in 2023. There […]
The post Cadrenal Therapeutics downsizes IPO, looks to raise $7 million first appeared on AlphaStreet.